Saw Palmetto Interactions and Safety Concerns

Short answer: Saw palmetto is generally well tolerated in adults, with mild and infrequent side effects reported in research lasting up to three years, according to the National Center for Complementary and Integrative Health (NCCIH). However, evidence for most of its promoted uses remains limited or insufficient, and certain groups, including pregnant people and those on hormone-related medications, should speak with a clinician before using it.

What Is Saw Palmetto?

Saw palmetto (Serenoa repens) is a small palm native to the southeastern United States. Its berries contain fatty acids and plant sterols that are proposed to influence androgen-related pathways in the body. It is widely marketed as a dietary supplement for urinary symptoms associated with benign prostatic hyperplasia (BPH), male-pattern hair loss, and chronic prostatitis or chronic pelvic pain syndrome.

It is important to note that dietary supplements are not intended to diagnose, treat, cure, or prevent any disease, and these statements have not been evaluated by the FDA. The sections below reflect graded evidence from NIH sources and are meant to help you have a more informed conversation with your healthcare provider.

Established Dosing and Upper Limits

According to the NIH Office of Dietary Supplements (ODS), no adult target intake and no established upper limit exist for saw palmetto. Because no reference values have been set, there is no population-wide number to guide personal dosing. Talk to a clinician or pharmacist to determine whether a specific product and amount is appropriate for your situation.

What the Evidence Shows

The NIH grades the research behind saw palmetto's promoted uses in the following way:

• Urinary symptoms from BPH (used alone) - Strong evidence that saw palmetto does not improve urinary tract symptoms of BPH beyond placebo. Multiple well-designed trials have not found a meaningful benefit over placebo when saw palmetto is used on its own.
• Effect on PSA levels or prostate cancer screening - Moderate evidence that saw palmetto does not appear to affect prostate-specific antigen (PSA) test readings, even at higher-than-usual amounts. This means it should not distort that particular lab value, which is a clinically relevant finding for anyone undergoing prostate cancer screening.
• Combination therapy for BPH or lower urinary tract symptoms (LUTS) - Limited evidence for saw palmetto combined with lycopene, selenium, and/or tamsulosin. Study results are not consistent enough to draw firm conclusions.
• Chronic prostatitis or chronic pelvic pain syndrome - Insufficient evidence. There is not enough quality research to support or rule out a benefit.
• Male-pattern hair loss (androgenetic alopecia) - Insufficient evidence. Current data are too limited to draw conclusions.

General Safety Profile

The NCCIH reports that saw palmetto is generally well tolerated. Adverse effects observed in clinical studies are described as mild and infrequent, and include:

• Digestive upset, such as nausea or stomach discomfort
• Dizziness
• Headache

Studies have used saw palmetto safely for up to three years, which provides some reassurance about medium-term use in the populations studied. That said, long-term safety data beyond three years are limited, and most research has focused on middle-aged and older men.

Populations Who Should Use Extra Caution

Pregnant and Breastfeeding People

The NCCIH states that saw palmetto may be unsafe during pregnancy or breastfeeding. Because it is theorized to influence androgen-related pathways, the potential for hormonal effects is a meaningful concern during pregnancy. Anyone who is pregnant, planning to become pregnant, or breastfeeding should avoid saw palmetto unless a qualified clinician has specifically reviewed the risks and benefits.

Women and Children

Very little is known about the safety of saw palmetto in women or children. Most clinical trials have enrolled adult men with BPH, leaving these groups without adequate safety data. Women and children should consult a clinician before considering use.

People Scheduled for Surgery

As with many herbal supplements, there is a theoretical concern around bleeding risk. The NIH advises that, as with any supplement, you should tell your clinician and pharmacist about saw palmetto use, particularly in the period around surgery. Most guidelines recommend disclosing all supplement use to your surgical team at least two weeks before a planned procedure.

Drug and Supplement Interactions

The NCCIH states that saw palmetto has not been shown to interact with medications in confirmed clinical studies. However, the following areas warrant a cautious, informed approach:

• 5-alpha-reductase inhibitors (such as finasteride or dutasteride): Because saw palmetto is theorized to affect androgen pathways, caution is reasonable when combining it with drugs that work through similar mechanisms. No clinically confirmed interaction is documented by NIH, but the theoretical overlap is worth discussing with a prescriber.
• Other hormone-related drugs: The same logic applies to testosterone therapies or other medications that influence androgen or estrogen activity. There is no confirmed interaction, but the pharmacological overlap is a reasonable reason to check with a clinician or pharmacist.
• Anticoagulants and antiplatelet drugs: Data are limited, but the general principle of disclosing supplement use applies here. If you take blood thinners such as warfarin or aspirin, inform your healthcare team before adding saw palmetto.

Because data are limited across all of these categories, the safest approach is to disclose saw palmetto use to every member of your care team, including your primary care provider, any specialists, and your pharmacist.

PSA Testing and Prostate Cancer Screening

One practically important finding from the research is that saw palmetto does not appear to change PSA levels, even at higher-than-usual amounts. This means it is unlikely to mask a rising PSA that could signal prostate cancer. Users should be aware, however, that this also means saw palmetto will not provide any protective effect on that screening result. Routine PSA monitoring should continue as recommended by your clinician regardless of saw palmetto use.

Key Takeaways

• No adult target intake or upper limit has been established by the NIH ODS for saw palmetto.
• It is generally well tolerated, with mild side effects and studies lasting up to three years.
• Evidence for improving urinary symptoms from BPH on its own is not supportive; most other promoted uses have limited or insufficient evidence.
• It does not appear to affect PSA test results.
• No confirmed drug interactions are documented, but theoretical concerns exist around hormone-related medications and bleeding risk.
• Pregnant people, breastfeeding people, women, and children should consult a clinician before use.
• Always tell your clinician and pharmacist about all supplements you take, especially before surgery or when starting a new prescription.